Clinical Trial Update: Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating carboplatin and paclitaxel with either pertuzumab and trastuzumab or bevacizumab for breast cancer; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• HERCEPTIN (trastuzumab)
• Perjeta (pertuzumab)
• Taxol (paclitaxel)

Snippet

Sponsor: University of California, Irvine | Conditions: Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING